CA3244360A1 - Compositions containing MEAI and N-acylethanolamines and their uses - Google Patents
Compositions containing MEAI and N-acylethanolamines and their usesInfo
- Publication number
- CA3244360A1 CA3244360A1 CA3244360A CA3244360A CA3244360A1 CA 3244360 A1 CA3244360 A1 CA 3244360A1 CA 3244360 A CA3244360 A CA 3244360A CA 3244360 A CA3244360 A CA 3244360A CA 3244360 A1 CA3244360 A1 CA 3244360A1
- Authority
- CA
- Canada
- Prior art keywords
- meai
- pharmaceutical composition
- alcohol
- certain embodiments
- consumption
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263317257P | 2022-03-07 | 2022-03-07 | |
| US63/317,257 | 2022-03-07 | ||
| PCT/IB2023/052091 WO2023170552A1 (en) | 2022-03-07 | 2023-03-06 | Compositions comprising meai and n-acylethanolamines and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3244360A1 true CA3244360A1 (en) | 2023-09-14 |
Family
ID=85706794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3244360A Pending CA3244360A1 (en) | 2022-03-07 | 2023-03-06 | Compositions containing MEAI and N-acylethanolamines and their uses |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250302773A1 (https=) |
| EP (1) | EP4489741A1 (https=) |
| JP (1) | JP2025508052A (https=) |
| CN (1) | CN119212690A (https=) |
| AU (1) | AU2023231494A1 (https=) |
| CA (1) | CA3244360A1 (https=) |
| IL (1) | IL315486A (https=) |
| MX (1) | MX2024010596A (https=) |
| WO (1) | WO2023170552A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120225185A (zh) * | 2022-09-21 | 2025-06-27 | 克力迈医药公司 | 5-甲氧基-2-氨基茚满(“meai”)在用于治疗代谢综合征的方法中的用途 |
| WO2025196662A1 (en) * | 2024-03-20 | 2025-09-25 | Clearmind Labs Corp. | Compositions and methods for treating eating disorders |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5114946A (en) | 1987-06-12 | 1992-05-19 | American Cyanamid Company | Transdermal delivery of pharmaceuticals |
| US4818541A (en) | 1987-08-19 | 1989-04-04 | Schering Corporation | Transdermal delivery of enantiomers of phenylpropanolamine |
| JP3342491B2 (ja) | 1993-08-06 | 2002-11-11 | ファルマシア・アンド・アップジョン・カンパニー | 選択的ドーパミンｄ３リガンドとしての２−アミノインダン類 |
| WO2005002524A2 (en) * | 2003-07-02 | 2005-01-13 | The Regents Of The University Of California | COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES OF OLEOYLETHANOLAMIDE-LIKE COMPOUNDS AND MODULATORS OF PPARα |
| CN107406369B (zh) * | 2014-12-09 | 2021-01-15 | 以西结·戈兰 | 放纵行为调节剂 |
| ES2580508B1 (es) * | 2016-04-11 | 2018-09-12 | Servicio Andaluz De Salud | Composiciones para la prevención y/o tratamiento de los trastornos por uso de alcohol. |
-
2023
- 2023-03-06 CN CN202380038816.0A patent/CN119212690A/zh active Pending
- 2023-03-06 CA CA3244360A patent/CA3244360A1/en active Pending
- 2023-03-06 EP EP23712345.0A patent/EP4489741A1/en active Pending
- 2023-03-06 WO PCT/IB2023/052091 patent/WO2023170552A1/en not_active Ceased
- 2023-03-06 JP JP2024553359A patent/JP2025508052A/ja active Pending
- 2023-03-06 IL IL315486A patent/IL315486A/en unknown
- 2023-03-06 US US18/844,341 patent/US20250302773A1/en active Pending
- 2023-03-06 AU AU2023231494A patent/AU2023231494A1/en active Pending
-
2024
- 2024-08-29 MX MX2024010596A patent/MX2024010596A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2025508052A (ja) | 2025-03-21 |
| CN119212690A (zh) | 2024-12-27 |
| EP4489741A1 (en) | 2025-01-15 |
| AU2023231494A1 (en) | 2024-09-05 |
| MX2024010596A (es) | 2025-01-09 |
| US20250302773A1 (en) | 2025-10-02 |
| WO2023170552A1 (en) | 2023-09-14 |
| IL315486A (en) | 2024-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7442095B2 (ja) | ベータ－ヒドロキシブチレート及びブタンジオールのｓ－エナンチオマー並びにその使用方法 | |
| CN101820884B (zh) | 用于治疗轻度认知缺损的吩噻嗪化合物 | |
| US20250302773A1 (en) | Compositions comprising meai and n-acylethanolamines and uses thereof | |
| WO2024166059A1 (en) | Compositions comprising n,n-dimethyltryptamine, optionally in combination with n-acylethanolamines and uses thereof | |
| EP1401424B1 (en) | Carbamate compounds for use in preventing or treating psychotic disorders | |
| EP4661857A1 (en) | Compositions comprising lysergic acid diethylamide, optionally in combination with n-acylethanolamines and uses thereof | |
| WO2024166058A1 (en) | Compositions comprising psilocybin, optionally in combination with n-acylethanolamines and uses thereof | |
| RU2464023C2 (ru) | Лекарственное средство для лечения фибромиалгии | |
| EP4590286A1 (en) | Use of 5-methoxy-2-aminoindan ("meai") in methods for treating metabolic syndrome | |
| US20250325500A1 (en) | Use of 5-methoxy-2-aminoindan ("meai") in methods for treating cocaine addiction | |
| US12263155B2 (en) | Combinations of monoamine oxidase inhibitors and serotonin receptor agonists and their therapeutic use | |
| WO2024171073A1 (en) | Compositions comprising 3,4-methylenedioxymethamphetamine, optionally in combination with n-acylethanolamines, and uses thereof | |
| EP4687861A1 (en) | Compositions comprising 5-methoxy-2-aminoindan for treatment of depression | |
| WO2024171075A1 (en) | Compositions comprising ibogaine, optionally in combination with n-acylethanolamines, and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A00 | Application filed |
Free format text: ST27 STATUS EVENT CODE: A-0-1-A10-A00-A101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION RECEIVED - PCT Effective date: 20240815 |
|
| A00 | Application filed |
Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A00-A102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: COMPLIANCE REQUIREMENTS DETERMINED MET Effective date: 20240820 |
|
| A15 | Pct application entered into the national or regional phase |
Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A15-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: NATIONAL ENTRY REQUIREMENTS DETERMINED COMPLIANT Effective date: 20240820 |
|
| P18 | Priority claim added or amended |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P18-P105 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRIORITY CLAIM REQUIREMENTS DETERMINED COMPLIANT Effective date: 20240820 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20241001 Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST TO REGISTER A DOCUMENT RECEIVED Effective date: 20241001 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REGISTER A DOCUMENT REQUIREMENTS DETERMINED COMPLIANT Effective date: 20241007 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250211 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD Year of fee payment: 2 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250225 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20250225 Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250225 |
|
| R11 | Change to the name of applicant or owner or transfer of ownership requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-R10-R11-R127 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TRANSFER RECORDAL REQUEST OR RESPONSE Effective date: 20251204 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20251204 |
|
| R14 | Transfer of ownership recorded |
Free format text: ST27 STATUS EVENT CODE: A-1-1-R10-R14-R129 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TRANSFER REQUIREMENTS DETERMINED COMPLIANT Effective date: 20251209 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260223 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260223 |